These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6889512)
1. Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma. Bosanquet AG; Gilby ED Eur J Cancer Clin Oncol; 1982 Apr; 18(4):355-62. PubMed ID: 6889512 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen. Woodhouse KW; Hamilton P; Lennard A; Rawlins MD Eur J Clin Pharmacol; 1983; 24(2):283-5. PubMed ID: 6840181 [TBL] [Abstract][Full Text] [Related]
3. Oral melphalan pharmacokinetics--relation to dose in patients with multiple myeloma. Ehrsson H; Eksborg S; Osterborg A; Mellstedt H; Lindfors A Med Oncol Tumor Pharmacother; 1989; 6(2):151-4. PubMed ID: 2747308 [TBL] [Abstract][Full Text] [Related]
4. The effect of food on oral melphalan absorption. Reece PA; Kotasek D; Morris RG; Dale BM; Sage RE Cancer Chemother Pharmacol; 1986; 16(2):194-7. PubMed ID: 3948305 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma. Bosanquet AG; Gilby ED Cancer Chemother Pharmacol; 1984; 12(3):183-6. PubMed ID: 6705135 [TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of melphalan during intermittent therapy of multiple myeloma. Loos U; Musch E; Engel M; Hartlapp JH; Hügl E; Dengler HJ Eur J Clin Pharmacol; 1988; 35(2):187-93. PubMed ID: 3191937 [TBL] [Abstract][Full Text] [Related]
8. Measurement of plasma melphalan at therapeutic concentrations using isocratic high-performance liquid chromatography. Bosanquet AG; Gilby ED J Chromatogr; 1982 Nov; 232(2):345-54. PubMed ID: 7153282 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases. Ardiet C; Tranchand B; Biron P; Rebattu P; Philip T Cancer Chemother Pharmacol; 1986; 16(3):300-5. PubMed ID: 3516430 [TBL] [Abstract][Full Text] [Related]
10. Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma. Taha IA; Ahmad RA; Gray H; Roberts CI; Rogers HJ Cancer Chemother Pharmacol; 1982; 9(1):57-60. PubMed ID: 7139852 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice. Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation. Pinguet F; Martel P; Fabbro M; Petit I; Canal P; Culine S; Astre C; Bressolle F Anticancer Res; 1997; 17(1B):605-11. PubMed ID: 9066587 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of high dose melphalan. Hersh MR; Ludden TM; Kuhn JG; Knight WA Invest New Drugs; 1983; 1(4):331-4. PubMed ID: 6678879 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of melphalan in children following high-dose intravenous injection. Taha IA; Ahmad RA; Rogers DW; Pritchard J; Rogers HJ Cancer Chemother Pharmacol; 1983; 10(3):212-6. PubMed ID: 6861266 [TBL] [Abstract][Full Text] [Related]
17. Renal function in the elimination of oral melphalan in patients with multiple myeloma. Adair CG; Bridges JM; Desai ZR Cancer Chemother Pharmacol; 1986; 17(2):185-8. PubMed ID: 3719900 [TBL] [Abstract][Full Text] [Related]
19. Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central Sweden. Osterborg A; Ahre A; Björkholm M; Björeman M; Brenning G; Gahrton G; Grimfors G; Gyllenhammar H; Hast R; Johansson B Acta Oncol; 1990; 29(6):727-31. PubMed ID: 2223143 [TBL] [Abstract][Full Text] [Related]
20. Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease. Tattersall MH; Jarman M; Newlands ES; Holyhead L; Milstead RA; Weinberg A Eur J Cancer (1965); 1978 May; 14(5):507-13. PubMed ID: 648565 [No Abstract] [Full Text] [Related] [Next] [New Search]